Disappearance of the mu-opiate receptor patches in the rat neostriatum following lesioning of the ipsilateral nigrostriatal dopamine pathway with 1-methyl-4-phenylpyridinium ion (MPP+): restoration by embryonic nigral dopamine grafts.
Using in vitro autoradiography, this study examined the binding of the selective mu-opiate receptor radiolabelled ligand, [3H]Tyr-D-Ala-Gly-Me-Phe-Gly-ol ([3H]DAGO) to the striatal sections of rats with long-term unilateral lesions of the nigrostriatal dopamine (DA) pathway induced by 1-methyl-4-phenylpyridinium ion (MPP+) and in animals bearing embryonic DA grafts implanted into the DA-depleted striatum. In the ipsilateral striatum of MPP+-lesioned animals, there was a complete disappearance of the mu-opiate receptor patches as well as the subcallosal streak. The normal pattern of mu-binding sites in the patches reappeared following reinnervation of the DA-depleted striatum by the DA-grafts. These findings suggest that mu-opiate receptor patches in the striatum are localised on nigrostriatal DA afferent terminals. However, it is possible that trans-synaptic or postsynaptic changes also contribute to the profound alterations in striatal mu-opiate binding patterns revealed in this study.